Pembrolizumab has robust, durable clinical benefit in patients with heavily pretreated CCGC and was tolerated in the overall population,” researchers wrote.

THIO sequenced with Libtayo extended overall survival in those with non–small cell lung cancer who progressed on two or more ...

With another trial win, Bristol Myers Squibb is touting Breyanzi as the CD19-directed CAR-T therapy with positive readouts in the most cancer types. | With another trial win, Bristol Myers Squibb is ...

ASH 2024 featured practice-changing studies in lymphoid malignancies, including tafasitamab’s impact in FL, ibrutinib’s OS benefit in MCL, and promising epcoritamab data in CLL.

CAR T-cell therapies have demonstrated efficacy in treating blood cancers but, so far, their safety and effectiveness in ...

Pelareorep plus chemotherapy with or without Tecentriq had an acceptable safety profile in patients with newly diagnosed ...

I’ve seen significant improvements over the past couple of years,” said Reece Bell, who normally commutes on BART to work ...

Prime Minister Narendra Modi is counting on a two-pronged stimulus of tax and interest rate cuts to turn around India’s ...

A submission by IFS researchers Kate Ogden and David Phillips to a government consultation on the principles and objectives of council funding reform.

The Croma Velocity AR Smartwatch comes with essential features like Bluetooth calling and water resistance, but does it truly ...

The Hain Celestial Group, Inc. ( NASDAQ: HAIN) Q2 2025 Earnings Conference Call February 10, 2025 8:00 AM ET Alexis Tessier - VP, IR Wendy Davidson - President & CEO Lee Boyce - CFO ...

On issues as varied as education and crime, Americans often have a rosier view of how things are going in their communities than in the nation as a whole.